| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.04 | 0.4 |